United Therapeutics Insider Sold Shares Worth $5,362,824, According to a Recent SEC Filing

05:47 PM EST, 11/09/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 06, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,362,824. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. Sales were pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000183/xslF345X05/primarydocument.xml